You are here

AusPAR: Elasomeran

Australian Public Assessment Report

4 August 2022
AusPAR Details
AusPAR
Active Ingredient
Elasomeran
Product Name
Spikevax
Sponsor
Moderna Australia Pty Ltd
Submission Number
PM-2022-01792-1-2 and PM-2022-01760-1-2
Submission Type
Extension of indication and major variation (new strength)
Decision
Approved for provisional registration
AusPAR Date
27 July 2022
Publication Date

4 August 2022